Custom Search Insider Trading Activity Insider Trading Activity

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Custom Search Insider Trading Activity

Updated Mar 31, 2021

Ticker
Company Name
Qty.
Price
Size ($)
Filing Date
Type
Δ Own
Own
Insider Names
Title
Trade Dates
Is Scheduled
Urovant Sciences Ltd.
-78.78K
—
—
-100.00%
0
Mar 29
Urovant Sciences Ltd.
44.35K
—
—
+135.07%
77.18K
+1
May 1
Urovant Sciences Ltd.
32.83K
—
—
∞
32.83K
+1
Jan 7
Urovant Sciences Ltd.
0
—
—
—
0
+1
Jan 6
Urovant Sciences Ltd.
0
—
—
—
0
Oct 15
Urovant Sciences Ltd.
0
—
—
—
0
Novus Therapeutics, Inc.
0
—
—
—
0
May 24
Novus Therapeutics, Inc.
10.01K
$9.99
$99,999.90
+86.44%
21.59K
May 10
Novus Therapeutics, Inc.
0
—
—
—
0
Avanir Pharmaceuticals, Inc.
-5.78K
$10.23
-$500,530.40
-5.04%
108.8K
+1
Dec 16 - Dec 18
Scheduled
Avanir Pharmaceuticals, Inc.
51.84K
—
—
+82.62%
114.58K
+1
Nov 10
Avanir Pharmaceuticals, Inc.
-2.08K
$11.81
-$24,564.80
-2.60%
77.79K
+1
Oct 24
Scheduled
Avanir Pharmaceuticals, Inc.
-55.00K
$9.45
-$519,750.00
-40.78%
79.87K
+1
Sep 15
Scheduled
Avanir Pharmaceuticals, Inc.
-2.11K
$6.10
-$12,871.00
-2.57%
79.87K
+1
Aug 26
Scheduled
Avanir Pharmaceuticals, Inc.
-37.50K
$5.01
-$189,379.48
-30.61%
84.98K
+1
May 14 - May 16
Avanir Pharmaceuticals, Inc.
44.38K
—
—
+70.21%
107.58K
+1
Feb 12
Avanir Pharmaceuticals, Inc.
-2.45K
$2.63
-$6,445.46
-3.73%
63.2K
+1
Dec 18
Scheduled
Avanir Pharmaceuticals, Inc.
0
—
—
—
0
+1
Dec 13
Avanir Pharmaceuticals, Inc.
-20.00K
$2.09
-$204,473.56
-23.35%
65.65K
+1
May 15
Scheduled
Avanir Pharmaceuticals, Inc.
30.25K
—
—
+54.60%
85.65K
+1
Dec 17
Avanir Pharmaceuticals, Inc.
-2.85K
$2.55
-$7,257.59
-4.88%
55.4K
+1
Dec 3
Scheduled
Avanir Pharmaceuticals, Inc.
0
$2.01
-$192,374.00
—
58.25K
+1
Sep 17
Scheduled
Avanir Pharmaceuticals, Inc.
3K
$2.60
$7,794.90
∞
3K
+1
Mar 6
Avanir Pharmaceuticals, Inc.
20K
—
—
+52.29%
58.25K
+1
Dec 15
Avanir Pharmaceuticals, Inc.
-2.68K
$2.38
-$6,371.82
-6.54%
38.25K
+1
Dec 2
Scheduled
Avanir Pharmaceuticals, Inc.
0
$1.76
-$159,674.77
—
40.92K
+1
Nov 11
Scheduled
Avanir Pharmaceuticals, Inc.
1.35K
—
—
+3.41%
40.92K
+1
Feb 17
Avanir Pharmaceuticals, Inc.
-13.66K
$3.79
-$51,771.40
-25.66%
39.57K
+1
Dec 6
Scheduled
Avanir Pharmaceuticals, Inc.
11.25K
$2.84
-$193,700.50
+26.80%
53.23K
+1
Dec 1 - Dec 3
Avanir Pharmaceuticals, Inc.
0
$2.09
-$57,671.69
—
41.98K
+1
Aug 11
Avanir Pharmaceuticals, Inc.
-15.52K
$2.08
-$32,283.12
-26.99%
41.98K
+1
Mar 16
Scheduled
Avanir Pharmaceuticals, Inc.
0
—
—
—
0
+1
Nov 27
Avanir Pharmaceuticals
11.9K
$0.44
$5,216.00
+20.70%
69.4K
+1
Feb 24
Avanir Pharmaceuticals
0
—
—
—
0
+1
Dec 16
Avanir Pharmaceuticals
0
—
—
—
0
+1
Oct 31 - Jul 31
Avanir Pharmaceuticals
0
—
—
—
0
+1
Cardiogenesis Corp /ca
0
—
—
—
0
+1
Mar 21
Cardiogenesis Corp /ca
20K
$0.44
$8,700.00
∞
20K
+1
May 19
Cardiogenesis Corp /ca
0
—
—
—
0
+1
Jan 14
Cardiogenesis Corp /ca
0
—
—
—
0

It looks like there's no data for these filter options. Maybe you'll be interested in these options instead.

Loading...

Want to view more results?

Unlock the hidden results with your Benzinga Account now. No purchase required.